Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 27 (Search time: 0.003 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2012	Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)	Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
	2015	TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets	Yeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
	2012	Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer	Khattak, M.; Townsend, A.; Beeke, C.; Karapetis, C.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
	2011	Efficacy of α-lactalbumin and milk protein on weight loss and body composition during energy restriction	Soenen, S.; Hochstenbach-Waelen, A.; Westerterp-Plantenga, M.
	2011	Anterior 180-degree partial fundoplication: A 16-year experience with 548 patients	Chen, Z.; Thompson, S.; Jamieson, G.; Devitt, P.; Game, P.; Watson, D.
	2010	Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond study	Dent, J.; Vakil, N.; Jones, R.; Bytzer, P.; Schnoning, U.; Halling, K.; Junghard, O.; Lind, T.
	2010	Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study	Saeed, P.; Blank, L.; Selva-Nayagam, D.; Wolbers, J.; Nowak, P.; Geskus, R.; Weis, E.; Mourits, M.; Rootman, J.
	2013	Smoking termination opportunity for in patients (STOP): Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: A 12-month randomised controlled trial for inpatients	Smith, B.; Carson, K.; Brinn, M.; Labiszewski, N.; Peters, M.; Fitridge, R.; Koblar, S.; Jannes, J.; Veale, A.; Goldsworthy, S.; Litt, J.; Edwards, D.; Esterman, A.
	2010	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)	Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
	2010	Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study	Cortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.